# The Role of CD34 + Stem Cells and Biomarkers in the Development of CAV in HTX Patients

> **NCT05485467** · — · COMPLETED · sponsor: **University Medical Centre Ljubljana** · enrollment: 55 (actual)

## Conditions studied

- Vasculopathy
- Heart Transplant Failure

## Interventions

- **DIAGNOSTIC_TEST:** coronary CT angiography

## Key facts

- **NCT ID:** NCT05485467
- **Lead sponsor:** University Medical Centre Ljubljana
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2022-06-01
- **Primary completion:** 2022-08-15
- **Final completion:** 2022-08-31
- **Target enrollment:** 55 (ACTUAL)
- **Last updated:** 2023-11-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05485467

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05485467, "The Role of CD34 + Stem Cells and Biomarkers in the Development of CAV in HTX Patients". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT05485467. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*